Heparin versus bivalirudin for non‐primary percutaneous coronary intervention: A post‐Hoc analysis of the CPORT‐E trial

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

    loading  Loading Related Articles